Alendronate is actually a bisphosphonate that binds to bone hydroxyapatite and specifically inhibits the activity of osteoclasts, the bone-resorbing cells.In individuals with postmenopausal osteoporosis dealt with with FOSAMAX 10 mg/day for one or two decades, the results of treatment withdrawal were assessed. Following discontinuation, there were